Effect of neonatal flow CPAP ventilator in the treatment of neonatal hyaline membrane disease
新生儿流量CPAP呼吸机治疗新生儿肺透明膜病的应用效果观察

摘要

目的 实验将针对新生儿肺透明膜病实施新生儿流量CPAP呼吸机治疗，针对应用后的实际效果做出统计分析。方法 针对80例新生儿肺透明膜病者进行治疗，样本选自2020年6月~2022年6月就诊的新生儿，并按照先后顺序分为2组，对照组为常规治疗，观察组为新生儿流量CPAP呼吸机治疗，对比治疗成果。结果 从数据可见，观察组患儿的病情控制的总有效率上高于对照组，对比差异显著（P＜0.05）。此外，在患者使用呼吸机时间以及给氧时间上，均以观察组低于对照组，且住院时间段，两组对比差异显著（P＜0.05）。同时，在治疗后两组pH值、PaO₂值以及PaCO₂血气指标对比，差异无统计学意义（P＞0.05）。最后，在不良反应发生率对比中，观察组低于对照组，两组对比差异显著（P＜0.05）。结论 采用新生儿流量CPAP呼吸机治疗对于新生儿肺透明膜病患者的康复治疗效果显著，有助于患儿病情控制，方案安全有效，有助于早日出院，值得在继承借鉴中发展。

Abstract

Objective This experiment will implement the neonatal flow CPAP ventilator therapy for neonatal hyaline membrane disease, and make statistical analysis for the actual effect after application.
Methods A total of 80 neonates with hyaline membrane disease were treated. The samples were selected from neonates who were treated from June 2020 to June 2022 and divided into two groups according to the order of treatment. The control group was treated with conventional treatment, and the observation group was treated with neonatal flow CPAP ventilator.
Results According to the data, the total effective rate of disease control in the observation group was higher than that in the control group, and the comparison difference was significant (P<0.05). In addition, the time of ventilator use and oxygen delivery in the observation group were lower than those in the control group, and the hospitalization time was significantly different between the two groups (P<0.05). At the same time, there was no significant difference in pH value, PaO₂ value and PaCO₂ blood gas index between the two groups after treatment (P>0.05). Finally, in the comparison of the incidence of adverse reactions, the observation group was lower than the control group, and the difference between the two groups was significant (P<0.05).
Conclusion   The use of neonatal flow CPAP ventilator for the rehabilitation of neonatal patients with hyaline membrane disease has a significant effect, which is helpful to the control of the disease, safe and effective, and conducive to early discharge, which is worthy of development in the inheritance and reference.